z-logo
open-access-imgOpen Access
Diminished Adherence and/or Ingestion of VirulentMycobacterium tuberculosisby Monocyte-Derived Macrophages from Patients with Tuberculosis
Author(s) -
Jovanny Zabaleta,
M Arias,
José R. Maya,
Luis F. García
Publication year - 1998
Publication title -
clinical and diagnostic laboratory immunology
Language(s) - English
Resource type - Journals
eISSN - 1098-6588
pISSN - 1071-412X
DOI - 10.1128/cdli.5.5.690-694.1998
Subject(s) - ingestion , tuberculosis , mycobacterium tuberculosis , macrophage , immunology , monocyte , integrin alpha m , microbiology and biotechnology , flow cytometry , medicine , receptor , phagocytosis , complement receptor , antibody , chemistry , biology , complement system , pathology , biochemistry , in vitro
The interaction between the macrophage andMycobacterium tuberculosis is mediated by a variety of macrophage membrane-associated proteins. Complement receptors have been implicated in the adherence ofM. tuberculosis to macrophages. In the present work, the adherence and/or ingestion ofM. tuberculosis H37Rv to human monocyte-derived macrophages (MDM) from patients with tuberculosis (TB) and healthy controls was measured by microscopical examination, [3 H]uracil incorporation, and CFU. The adherence and/or ingestion was enhanced by fresh serum and inhibited by heat inactivation, EDTA treatment, and anti-CR1 and anti-CR3 antibodies. Comparison of MDM from TB patients and healthy controls showed that the former exhibited a significantly decreased capacity to adhere and/or ingestM. tuberculosis , as determined by the number of CFU and3 H incorporation. The expression of CR1 (CD35) and CR3 (CD11b/CD18) on MDM from TB patients and healthy controls, as determined by flow cytometry, did not show significant differences. These results suggest that the lower ingestion ofM. tuberculosis by MDM from TB patients is not due to defects in complement receptors, and therefore, there might be other molecules involved in the adherence and/or ingestion process that render MDM from TB patients ingest less mycobacteria than those from healthy controls.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom